Cyclosporine levels in the early posttransplant period: predictive of chronic rejection in liver transplantation?

Transplant Proc. 1995 Feb;27(1):1129-30.

Authors

A S Soin¹, A Rasmussen, N V Jamieson, Y Tokat, C J Watson, P J Friend, D G Wight, R Y Calne

Affiliation

¹ University of Cambridge Clinical School, UK.

PMID: 7878821

No abstract available

Publication types

Clinical Trial

MeSH terms

Adolescent
Adult
Aged
Antilymphocyte Serum / therapeutic use
Azathioprine / therapeutic use
Child
Child, Preschool
Cyclosporine / blood*
Cyclosporine / therapeutic use
Dose-Response Relationship, Drug
Female
Graft Rejection / diagnosis*
Graft Rejection / epidemiology
Graft Rejection / therapy
Humans
Incidence
Infant
Liver Transplantation / immunology*
Male
Middle Aged
Muromonab-CD3 / therapeutic use
Predictive Value of Tests
Risk Factors
Steroids / therapeutic use

Substances

Antilymphocyte Serum
Muromonab-CD3
Steroids
Cyclosporine
Azathioprine